- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Phase 3 Trial
Recent news which mentions Phase 3 Trial
Galmed's NASH Candidate Shows Clinically Significant Effect On Fibrosis Improvement
November 08, 2021
Tickers
GLMD
From Benzinga
GlaxoSmithKline Spotlights Encouraging Data For Anemia Drug
November 08, 2021
Tickers
GSK
From Benzinga
Bristol Myers' Opdivo Combo Meets Endpoint Goal In Lung Cancer Trial
November 08, 2021
Tickers
BMY
From Benzinga
From Benzinga
Why Did Deciphera Stock Plunged 70% Today?
November 05, 2021
From Benzinga
Galmed Reveals Early Aramchol Data From Late-Stage NASH Trial
November 01, 2021
Tickers
GLMD
From Benzinga
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
November 01, 2021
Tickers
TEVA
From Benzinga
From Benzinga
AbbVie's Major Depressive Disorder Candidate Shows Mixed Result In Late-Stage Trials
October 29, 2021
Tickers
ABBV
From Benzinga
AstraZeneca's Imfinzi/Chemo Combo Strikes First Immunotherapy Wins In Bile Duct Cancer Trial
October 26, 2021
From Benzinga
ObsEva Presents Linzagolix Data From Uterine Fibroid Trials
October 20, 2021
Tickers
OBSV
From Benzinga
Edesa Biotech Shares Gain As Its COVID-19 Antibody Shows Favorable Mortality Reductions
October 19, 2021
Tickers
EDSA
From Benzinga
Why Did Galera Therapeutics Shares Plunge To All Time Lows Today?
October 19, 2021
Tickers
GRTX
From Benzinga
Entasis Shares Rally On Positive Data From Drug-Resistant Bacterial Infection Candidate
October 19, 2021
Tickers
ETTX
From Benzinga
From Benzinga
Phathom's Vonoprazan Non-Inferior To Proton Pump Inhibitor For Esophagitis Inflammation
October 18, 2021
Tickers
PHAT
From Benzinga
Why Are Valneva's Shares Trading Higher Monday Premarket?
October 18, 2021
From Benzinga
From Benzinga
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
From Benzinga
AbbVie Touts Additional Rinvoq Data In Inflammatory Spinal Arthritis
October 07, 2021
Tickers
ABBV
From Benzinga
Brickell Biotech Aces Pivotal Sofpironium Trials In Patients With Excessive Underarm Sweating
October 07, 2021
Tickers
BBI
From Benzinga
From Benzinga
AbbVie Unveils New Durable Risankizumab Data In Psoriatic Arthritis
September 30, 2021
Tickers
ABBV
From Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
September 30, 2021
Tickers
NERV
From Benzinga
Eli Lilly Shares Positive Tirzepatide Data At EASD Annual Meeting
September 30, 2021
Tickers
LLY
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.